Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinhang Zhang

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Molecular Pharmaceutics|January 30, 2026
Chondroitin Sulfate-Based ROS-Responsive Nanoparticles Targeting Activated Myofibroblasts via CD44 Receptors for the Renal Fibrosis TherapyWei Zhao, Jie Zhou, Yan Xia, et al.
Journal of Pharmaceutical Analysis|January 15, 2024
Glutaredoxin-1 alleviates acetaminophen-induced liver injury by decreasing its toxic metabolitesYing Xu, Yan Xia, Qinhui Liu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 21, 2019
An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosisYanping Li, Shiyun Pu, Qinhui Liu, et al.
Biomaterials|July 7, 2023
Dually fibronectin/CD44-mediated nanoparticles targeted disrupt the Golgi apparatus and inhibit the hedgehog signaling in activated hepatic stellate cells to alleviate liver fibrosisYanping Li, Ting Zhang, Jinhang Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 7, 2025
A two-pronged nanomedicine counteracts obesity by remodeling adipose nicheLingling Wang, Jiahao Chen, Jingwei Li, et al.
Metabolism: Clinical and Experimental|June 5, 2023
Glutaredoxin 1 regulates cholesterol metabolism and gallstone formation by influencing protein S-glutathionylationYan Xia, Ying Xu, Qinhui Liu, et al.
Drug Design, Development and Therapy|May 27, 2021
Canagliflozin Facilitates Reverse Cholesterol Transport Through Activation of AMPK/ABC Transporter PathwayYingnan Zhao, Yanping Li, Qinhui Liu, et al.
Biochemical and Biophysical Research Communications|January 18, 2020
Telmisartan attenuates obesity-induced insulin resistance via suppression of AMPK mediated ER stressYa Huang, Yanping Li, Qinhui Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 15, 2021
Blocking 5-LO pathway alleviates renal fibrosis by inhibiting the epithelial-mesenchymal transitionJian Zhou, Rui Li, Qinhui Liu, et al.
Molecular Pharmaceutics|October 22, 2020
SB431542-Loaded Liposomes Alleviate Liver Fibrosis by Suppressing TGF-β SignalingJinhang Zhang, Rui Li, Qinhui Liu, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Molecular Pharmaceutics|January 30, 2026
Chondroitin Sulfate-Based ROS-Responsive Nanoparticles Targeting Activated Myofibroblasts via CD44 Receptors for the Renal Fibrosis TherapyWei Zhao, Jie Zhou, Yan Xia, et al.
Journal of Pharmaceutical Analysis|January 15, 2024
Glutaredoxin-1 alleviates acetaminophen-induced liver injury by decreasing its toxic metabolitesYing Xu, Yan Xia, Qinhui Liu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 21, 2019
An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosisYanping Li, Shiyun Pu, Qinhui Liu, et al.
Biomaterials|July 7, 2023
Dually fibronectin/CD44-mediated nanoparticles targeted disrupt the Golgi apparatus and inhibit the hedgehog signaling in activated hepatic stellate cells to alleviate liver fibrosisYanping Li, Ting Zhang, Jinhang Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 7, 2025
A two-pronged nanomedicine counteracts obesity by remodeling adipose nicheLingling Wang, Jiahao Chen, Jingwei Li, et al.
Metabolism: Clinical and Experimental|June 5, 2023
Glutaredoxin 1 regulates cholesterol metabolism and gallstone formation by influencing protein S-glutathionylationYan Xia, Ying Xu, Qinhui Liu, et al.
Drug Design, Development and Therapy|May 27, 2021
Canagliflozin Facilitates Reverse Cholesterol Transport Through Activation of AMPK/ABC Transporter PathwayYingnan Zhao, Yanping Li, Qinhui Liu, et al.
Biochemical and Biophysical Research Communications|January 18, 2020
Telmisartan attenuates obesity-induced insulin resistance via suppression of AMPK mediated ER stressYa Huang, Yanping Li, Qinhui Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 15, 2021
Blocking 5-LO pathway alleviates renal fibrosis by inhibiting the epithelial-mesenchymal transitionJian Zhou, Rui Li, Qinhui Liu, et al.
Molecular Pharmaceutics|October 22, 2020
SB431542-Loaded Liposomes Alleviate Liver Fibrosis by Suppressing TGF-β SignalingJinhang Zhang, Rui Li, Qinhui Liu, et al.
Pageof 5